mlanger , vor 16 Tagen

@arstechnica Weight loss, lower risk of cancer. What's the catch?

svgeesus , vor 16 Tagen

@arstechnica "Lower risk" and "lower risk compared to insulin" are very different things.

gavin57 , vor 16 Tagen

@arstechnica As obesity is a risk factor in a number of cancers, I'd suggest the link is the lower body mass rather than the semaglutide.

The increased risk of kidney cancer is also not ideal.

dzwiedziu , vor 16 Tagen

@arstechnica
As a former semaglutide enjoyer, with enormous benefits, that had to quit and couldn't start again because of shortages I can say only about those preliminaries results, that now it will be even more unavailable, more overpriced Nordisk stocks will skyrocket, and less people will have help.

Nationalise health and pharma providers.

pikesley , vor 16 Tagen

@arstechnica did you mean Type-2 diabetes?

titaniumbiscuit , vor 16 Tagen

@arstechnica it really does everything, doesn't it?